India's Panacea Biotec to produce 100 million Sputnik V doses annually: RDIF
RDIF did not say when production would begin
FILE PHOTO: A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V Covid-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
Keep updated, follow The Business Standard's Google news channel
